 |
Products |  |
Diseases | | Products |
|
Trials |  |
News |  |
- | octohydroaminoacridine succinate - Changchun Huayang High / tech
Trial completion date, Trial primary completion date: Octohydroaminoacridine Succinate Tablet for Mild-to-Moderate Alzheimer's Disease (clinicaltrials.gov) - Oct 22, 2019
P3, N=600, Recruiting, Sponsor: Shanghai Mental Health Center
Trial completion date: Feb 2020 --> Feb 2021 | Trial primary completion date: Sep 2019 --> Sep 2020
- |||||||||| octohydroaminoacridine succinate - Changchun Huayang High / tech
New P3 trial: Octohydroaminoacridine Succinate Tablet for Mild-to-Moderate Alzheimer's Disease (clinicaltrials.gov) - Sep 13, 2017
P3, N=600, Recruiting, Sponsor: Shanghai Mental Health Center
- ||||| octohydroaminoacridine succinate - Changchun Huayang High / tech
New P2 trial: Study of Octohydroaminoacridine Succinate Tablets in Patients With Alzheimer's Disease (clinicaltrials.gov) - Mar 29, 2012
P2, N=288, Recruiting, Sponsor: Changchun Huayang High-tech Co., Ltd